Endoluten — EU research guide.
Endoluten is a Khavinson-series peptide bioregulator derived from the pineal-hypothalamic neuroendocrine complex, proposed to support circadian rhythmicity and melatonin biosynthesis. It is frequently paired with Epitalon in Eastern European longevity protocols, since both target pineal gland function from different angles — Epitalon synthetically, Endoluten as a natural tissue complex.
What is Endoluten?
Endoluten is a Khavinson-series peptide bioregulator derived from the pineal-hypothalamic neuroendocrine complex, proposed to support circadian rhythmicity and melatonin biosynthesis. It is frequently paired with Epitalon in Eastern European longevity protocols, since both target pineal gland function from different angles — Epitalon synthetically, Endoluten as a natural tissue complex.
What does the research show?
Available data is limited to small cohort and animal studies from the originating research group, focused on circadian and neuroendocrine aging markers. As with Epitalon, most of the telomere- and longevity-related claims attached to this compound class come from the same limited research lineage rather than broad independent replication.
EU legal status
Not approved as a medicine anywhere in the EU. Available from a small number of specialist research vendors for laboratory use only.
Molecular information
Pharmacokinetics
Endoluten is not yet in our price comparison
We expand EU supplier coverage every month.